Osteo3

SIRAKOSS Receives CE Mark for Osteo3 Synthetic Bone Graft Substitute

January 31, 2019 ABERDEEN, Scotland–(BUSINESS WIRE)–SIRAKOSS Ltd, a developer of unique synthetic bone graft substitutes, announced today it has been…